|
Simultaneous Sessions
Tuesday, December 12, 2006: 8:00 a.m. - 10:00 a.m.
- Hemolysis, Transfusion, and End Organ Dysfunction in Sickle Cell Disease, Room 311 E-H
- T-Cell Function and Signaling, Room 240
- Abnormalities of Megakaryocytes and Platelets, Room 414 CD
- Coagulation and Hemophilia, Room 414 AB
- Antithrombotic Therapy: Prophylaxis and Treatment of Thrombotic Disorders, Room 312
- Stem Cell Signaling, Room 224 ABEF
- Hematopoiesis: Regulation of Gene Transcription, Room 304 A-D
- Chromatin Modification and Leukemogenic Fusion Proteins, Room 304 E-H
- Dysregulated Transcription Factors in Leukemogenesis, Room 314
- Mechanisms of Resistance: Determinants of Response, Room 315
- Leukemias: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis - Acute Myeloid Leukemia (AML), Room 230
- Acute Lymphocytic Leukemia: Biology and Pathophysiology Valencia, Room D
- Lymphoma Biology: Gene Expression and Prognosis in Diffuse Large B-Cell Lymphomas, Halls F3-F4
- Lymphoma Biology: Susceptibility, Familial Risk, and Follicular Lymphoma Biology, Hall F5
- Lymphoma: Pre-Clinical - Chemotherapy and Biologic Agents II, Room 311 A-D
- Chronic Myeloid Leukemia: Targeting Mutated BCR-ABL and Advanced Disease, Valencia Room A
- Chronic Myeloid Leukemia: Molecular Surveillance and Biology of the Disease, Valencia Room BC
- Myelodysplastic Syndromes: Molecular Biology, Room 330
- Multiple Myeloma: Novel Targeted Therapy, Room 110
- Induction Therapy for Newly Diagnosed Myeloma, Halls F1-F2
- Bio-Processing and Ex-Vivo Expansion for Immunotherapy, Room 224 CDGH
- Clinical Care: Acute and Chronic Graft-Versus-Host Disease (GVHD), Room 109
|
